HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Dana v. Kao Ya

This article was originally published in The Rose Sheet

Executive Summary

Lawsuit filed by New Dana and affiliate, New Tinkerbell, against Kao Ya Manufacturing seeks more than $5 mil. in damages, firms announce Jan. 17. Filed in Scranton, Penn. federal court, suit alleges Kao Ya manufactured contaminated products formulated without preservatives. Products were slated for sale under Tinkerbell fragrances and cosmetics, but did not reach consumer market. New Dana had to postpone sales contracts with retail customers and incur costs to redeliver and dispose of products, firm asserts, claiming Kao Ya breached its contract by creating defective products. Separately, New Dana completes senior debt refinancing through $30 mil. facility, sponsored by LaSalle Business Credit (New York)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008853

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel